Terms: = Sarcomas AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
25 results:
1. FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Guo J; Liao Z; Chen Q; Dong A; Huang M
Clin Nucl Med; 2023 Dec; 48(12):1111-1113. PubMed ID: 37882056
[TBL] [Abstract] [Full Text] [Related]
2. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.
Guo W; Wang X; Lu B; Yu J; Xu M; Huang R; Cheng M; Yang M; Zhao W; Zou C
Cell Death Dis; 2023 Jul; 14(7):439. PubMed ID: 37460542
[TBL] [Abstract] [Full Text] [Related]
3. Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides.
Subrahmanyam N; Yathavan B; Yu SM; Ghandehari H
Mol Pharm; 2023 Mar; 20(3):1670-1680. PubMed ID: 36724294
[TBL] [Abstract] [Full Text] [Related]
4. The Role of FDG-PET and Whole-Body MRI in High Grade Bone sarcomas With Particular Focus on Osteosarcoma.
Farina A; Gasperini C; Aparisi Gómez MP; Bazzocchi A; Fanti S; Nanni C
Semin Nucl Med; 2022 Sep; 52(5):635-646. PubMed ID: 34879906
[TBL] [Abstract] [Full Text] [Related]
5. Clinical experience with the treatment of retroperitoneal vascular leiomyosarcoma originating from large veins.
Zhang HX; Wang K; Hong P; Lu M; Liu Z; Liu L; Wang GL; Ma LL
BMC Surg; 2021 Aug; 21(1):326. PubMed ID: 34392834
[TBL] [Abstract] [Full Text] [Related]
6. Inflammatory Undifferentiated Pleomorphic Sarcoma Mimicking Bacteremia in an Elderly Patient: A Case Report.
Hashimoto K; Nishimura S; Ito T; Oka N; Akagi M
Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670681
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Factors and Survival Time in Patients with Small Bowel Tumors: A Retrospective Observational Study.
Taghipour Zahir S; Heidarymeybodi Z; AleSaeidi S
Int J Surg Oncol; 2019; 2019():2912361. PubMed ID: 31186956
[TBL] [Abstract] [Full Text] [Related]
8. maximum standardized uptake value on
Rhu J; Hyun SH; Lee KH; Jo SJ; Lee KW; Park JB; Kim SJ
Sci Rep; 2019 Apr; 9(1):6605. PubMed ID: 31036901
[TBL] [Abstract] [Full Text] [Related]
9. Relationship of peak serum methotrexate concentration to prognosis and drug tolerance in non-metastatic extremity osteosarcomas.
Wang B; Yao H; Xie X; Yin J; Zou C; Huang G; Shen J
Cancer Chemother Pharmacol; 2018 Aug; 82(2):221-227. PubMed ID: 29808416
[TBL] [Abstract] [Full Text] [Related]
10. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma.
Akin S; Dizdar O; Karakas Y; Turker A; Kars A
Curr Probl Cancer; 2018; 42(3):344-349. PubMed ID: 29576383
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of
Umemura H; Yamasaki O; Kaji T; Hamada T; Otsuka M; Asagoe K; Iwatsuki K
J Dermatol; 2017 Sep; 44(9):1046-1049. PubMed ID: 28370268
[TBL] [Abstract] [Full Text] [Related]
12. Pretreatment tumor SUV
Ha SC; Oh JS; Roh JL; Moon H; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):33-40. PubMed ID: 27448574
[TBL] [Abstract] [Full Text] [Related]
13. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
[TBL] [Abstract] [Full Text] [Related]
14. A Phase II Study of Gemcitabine, Vincristine, and Cisplatin As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma.
Luo Z; Zhang X; Peng W; Wu X; Wang H; Yu H; Wang J; Chang J; Hong X
Medicine (Baltimore); 2015 Oct; 94(43):e1777. PubMed ID: 26512574
[TBL] [Abstract] [Full Text] [Related]
15. Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas.
Skamene SR; Rakheja R; Dahlstrom KR; Roberge D; Nahal A; Charest M; Turcotte R; Hickeson M; Freeman C
J Surg Oncol; 2014 Apr; 109(5):410-4. PubMed ID: 24310279
[TBL] [Abstract] [Full Text] [Related]
16. [Evaluation of selected cytokines in children and adolescents with osteosarcoma at diagnosis - preliminary report].
Markiewicz K; Zeman K; Kozar A; Gołebiowska-Wawrzyniak M
Med Wieku Rozwoj; 2011; 15(1):25-31. PubMed ID: 21786509
[TBL] [Abstract] [Full Text] [Related]
17. Metastatic leiomyosarcoma in the oral cavity: case report with protein expression profiles.
Kim SM; Myoung H; Choung PH; Kim MJ; Lee SK; Lee JH
J Craniomaxillofac Surg; 2009 Dec; 37(8):454-60. PubMed ID: 19664933
[TBL] [Abstract] [Full Text] [Related]
18. Risk assessment based on FDG-PET imaging in patients with synovial sarcoma.
Lisle JW; Eary JF; O'Sullivan J; Conrad EU
Clin Orthop Relat Res; 2009 Jun; 467(6):1605-11. PubMed ID: 19048352
[TBL] [Abstract] [Full Text] [Related]
19. Differential enhancement of collagen crosslink excretion in cases of osteosarcoma and chondrosarcoma.
Açil Y; Springer I; Behrens P; Ullrich KP; Hedderich J; Bruns J
J Cancer Res Clin Oncol; 2003 Oct; 129(10):583-8. PubMed ID: 14513370
[TBL] [Abstract] [Full Text] [Related]
20. 18FDG PET scanning of benign and malignant musculoskeletal lesions.
Feldman F; van Heertum R; Manos C
Skeletal Radiol; 2003 Apr; 32(4):201-8. PubMed ID: 12652335
[TBL] [Abstract] [Full Text] [Related]
[Next]
